Stem cells from umbilical cord blood successfully treat 5-year-old child with autism.
Salvador, a five-year-old Portuguese boy diagnosed with autism spectrum disorder, recently underwent treatment with stem cells from his own umbilical cord blood in an effort to improve his condition.
Cord blood stem cells are FDA-approved to treat more than 80 diseases, including childhood leukemia and sickle cell disease, and are being studied in hundreds of other clinical trials, including for autism. Salvador’s parents never imagined that these stem cells would be the key to reducing the severity of his autism.
In August 2022, through a single 15-minute procedure, Salvador’s cord blood stem cells reduced the severity of his autism from Level 2 (moderate to mild) to Level 1.